Targeted Nanomedicine for Breast Cancer Therapy (e-bog) af -
Paliwal, Rishi (redaktør)

Targeted Nanomedicine for Breast Cancer Therapy e-bog

2190,77 DKK (inkl. moms 2738,46 DKK)
Targeted Nanomedicine for Breast Cancer Therapy provides a compilation of treatment approaches for breast cancer, including conventional receptor targeting methods and novel strategies like stimuli responsive methods and tumor micro-environment responsive strategies. This book compiles the most important information on the state-of-the-art therapeutics, including breast cancer biomarkers and de...
E-bog 2190,77 DKK
Forfattere Paliwal, Rishi (redaktør)
Udgivet 6 august 2022
Længde 562 sider
Genrer Manufacturing industries
Sprog English
Format pdf
Beskyttelse LCP
ISBN 9780323860048
Targeted Nanomedicine for Breast Cancer Therapy provides a compilation of treatment approaches for breast cancer, including conventional receptor targeting methods and novel strategies like stimuli responsive methods and tumor micro-environment responsive strategies. This book compiles the most important information on the state-of-the-art therapeutics, including breast cancer biomarkers and design principles of bio-responsive nanosystems. Presented in two parts, sections cover basic and receptor mediated targeting approaches and examine tumor microenvironment mediated approaches. This is a useful book for pharmaceutical scientists and basic and clinical scientists working in the research area of breast cancer and drug discovery both from academics and industry.Worldwide, breast cancer is the most common cancer in women, however, breast cancer therapy is always challenging. This book aims to help researchers remain updated on the most targeted nanomedicine research available. Highlights promising breast cancer targets to help design nanomedicines and stimuli-triggered methods for cancer imaging and treatments Provides in-depth exploration of targeted breast cancer therapy, along with highlights to quickly understand the most important points Explores cutting-edge research in the area of targeted nanomedicine and drug delivery, including nanotheranostics for breast cancer therapy